SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1158A german VC makes the case for the munching of "-omics" companies. (Atuck-11/12/2001
1157Meaning ivgn still looks to grow by acquisition. Also means recognized INCY at keokalani'nui-11/7/2001
1156The implications of the first few paragraphs are not exactly flattering to eithenigel bates-11/6/2001
1155Curious story - IVGN/INCY - from Genomeweb genomeweb.com nignigel bates-11/6/2001
1154Several select biotechs doing well (see biobiznet.com). On the site, their were blackmerlin-11/3/2001
1153<i>And there is talk that Ciphergen is buyout bait--like Vysis, a maker ofscaram(o)uche-11/2/2001
1152Protein-Rich at Ciphergen? NOVEMBER 12, 2001 INSIDE WALL STREET [BW] Institsim1-11/2/2001
1151In the FWIW category - NEW YORK, Nov 1 (Reuters) - Biotechnology research firm nigel bates-11/2/2001
1150ALTANA AG Takes Minority Equity Stake in GPC Biotech AG MARTINSRIED and MUNICH,nigel bates-11/1/2001
1149<i>one product and not much else</i> What, you don't count the nigel bates-10/24/2001
1148Ian, Interesting speculation. It's often little tea-leave readings like thiBiomaven-10/24/2001
1147Some wild speculation on my part... QLTI PR stated they hired a new CFO today wIan@SI-10/24/2001
1146ABBOTT PARK, Ill. and DOWNERS GROVE, Ill., Oct. 24 /PRNewswire/ -- Abbott Laboranigel bates-10/24/2001
1145No-one posted the Bioglan unmunch debacle. In case anyone is interested - ftmarknigel bates-10/22/2001
1144COR: Biotech Bait? INSIDE WALL STREET [BW] OCTOBER 29, 2001 Is COR Therapeusim1-10/20/2001
1143NEW YORK, Oct 4 (Reuters) - Merger talks between Britain's Celltech Group Plnigel bates-10/4/2001
1142Bayer to Buy Aventis CropScience The Associated Press Tuesday, October 2, 2001sim1-10/3/2001
1141Is Aventis likely to go shopping with some of the Bayer cash ? nignigel bates-10/2/2001
1140mini munch Orchid to Acquire Lifecodes - Expected 2002 Total Revenues of Combindalroi-10/1/2001
1139OK, let's see more. Let's keep this ball rolling. Forensics and identiscaram(o)uche-10/1/2001
1138At 9 Euros, I once calculated it at USD1.6b. If they had any financings or splikeokalani'nui-9/27/2001
1137<i>``At this price, it's cheaper to buy the company than to invest in nigel bates-9/27/2001
1136Zeltia soars amid J&J bid speculation (UPDATE: Adds analyst comments in 8th,keokalani'nui-9/27/2001
1135Wilder, It is probably not true that the best individual biotech investments arjayhawk969-9/25/2001
1134>> MLNM M&A quest for products is a sad commentary on their internal dscaram(o)uche-9/25/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News